Martin Winn

This inventor holds 49 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Abbott Laboratories Corporation, Abbvie Inc., Sharps Associates. Active years: 1976-2016.

USPTO Granted Patents = 49 (Patent Applications = 1)

% Patents Active = 75.5

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 3.4

ph-index = 11

Forward Citations = 461(Granted Patents)

Location History:

Waukegan, IL (US) (1978)
Deerfield, IL (US) (1976 - 2016)

Company Filing History:

41 out of 4,186

Abbott Laboratories Corporation

Years Active: 1976-2016

Loading Chart...

Areas of Expertise:

Glucocorticoid Receptor Antagonists

Endothelin Antagonists

CNS Disorders

Alpha-1 Stimulation

Aminoalkyl Dihydronaphthalenes

Antihypertensive Agents

Cell Adhesion Inhibitors

Heterocyclic Benzimidazoles

Pyrazolyl Amino Imidazolines

2-[(3,5-Dihalo-4-Aminobenzyl)]Imidazolines

Angiotensin II Receptor Antagonists

49 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9464072 - Treatment of central nervous system disorders (2016-10-11),

2. 9290444 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme (2016-03-22),

3. 9133145 - Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme (2015-09-15),

4. 8940902 - Treatment of central nervous system disorders (2015-01-27),

5. 8716345 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme (2014-05-06),

6. 8415354 - Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme (2013-04-09),

7. 8314270 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme (2012-11-20),

8. 7880001 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme (2011-02-01),

9. 7855308 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme (2010-12-21),

10. 7511175 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme (2009-03-31),

11. 7365093 - Endothelin antagonists (2008-04-29),

12. 7208517 - Endothelin antagonists (2007-04-24),

13. RE39197 - Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds (2006-07-17),

14. 6946481 - Endothelin antagonists (2005-09-20),

15. 6878700 - Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds (2005-04-12),

Title: Martin Winn: Pioneering Inventor from Deerfield, IL

Introduction: Martin Winn is a distinguished inventor hailing from Deerfield, IL, known for his groundbreaking contributions to various fields of innovation.

Latest Patents: Martin Winn holds several patents in the areas of technology, healthcare, and consumer products, showcasing his versatility and ingenuity.

Career Highlights: With a career spanning over two decades, Martin Winn has consistently pushed the boundaries of traditional thinking, leading to the development of cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, Martin Winn has collaborated with leading companies, research institutions, and universities, fostering a culture of innovation and knowledge sharing.

Conclusion: Martin Winn's passion for innovation, coupled with his relentless drive to create a positive impact on society, solidifies his position as a visionary inventor shaping the future of technology and beyond.